GlassScriptPhysician profile
Jeffrey Brian Comitalo
NPI 1679567697
$1,214.48
in general payments reported to CMS, 2019-2025
27 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.27 · 2020: $60.98 · 2021: $28.36 · 2022: $307 · 2023: $260 · 2024: $150 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $724.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $307.30 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Davol INC. | $87.40 | 2023-2025 | Phasix Mesh |
| Intuitive Surgical, INC. | $77.40 | 2025 | |
| Baxter Healthcare | $70.42 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $53.72 | 2023 | Libtayo |
| Abbott Laboratories | $51.56 | 2022-2025 | Eterna |
| Zimvie INC. | $47.40 | 2022-2023 | |
| Medtronic, INC. | $47.01 | 2021-2024 | Ligasure |
| Si-Bone, INC. | $46.07 | 2021-2024 | |
| Kerecis Limited | $45.52 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Radius Health, INC. | $40.66 | 2023-2024 | Tymlos |
| Cerapedics INC. | $39.00 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Genzyme Corporation | $33.38 | 2019-2022 | |
| Mimedx Group, INC. | $30.85 | 2025 | |
| Conmed Corporation | $28.77 | 2024 | Airseal |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $24.26 | 2019 | |
| Organogenesis INC. | $22.81 | 2022 | |
| Solventum Corporation | $21.99 | 2024 | Prevena, V.A.C. Veraflo |
| Vericel Corporation | $17.17 | 2022 | |
| Bioventus LLC | $16.85 | 2024 | Durolane |
| Merck Sharp & Dohme LLC | $16.13 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.87 | 2022 | |
| Hologic Sales and Service, LLC | $15.76 | 2025 | Sentimag |
| Orthofix Medical, INC. | $15.19 | 2022 | |
| Merit Medical Systems INC | $14.75 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.49 | 2022 | |
| Focal Therapeutics, INC. | $12.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Comitalo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.